We wrapped up the final day of the BC3 with our final two sessions and one of the highlights was our onsite cadaver lab. This gave attendees a unique opportunity to learn firsthand from experts and get hands on experience.
🗽 Until next time… see you in NYC in 2028!
#BC326#CE
That's a Wrap on Day 2 of BC3 in Washington, DC!
We heard from our keynote speaker Ashley Hendrix, MD, MBA and her talk on Pixels to Prognosis: AI’s Growing Role in Breast Care.
Thank you to our nationally recognized speakers, for making this another memorable day!
#BC326#CE
🎀What an incredible start to BC3!
Day 1 was filled with engaging discussions and valuable insights from leaders in breast cancer care. We also heard from our top 3 abstract authors with oral presentations.
We're looking forward to Day 2.
#BC3#BreastCancer#CE
Great news for breast cancer patients:
In a new study, an AI model helped predict chemotherapy benefit better than the Oncotype DX molecular test. The test was developed by Ataraxis AI, who is also sponsoring BC3 2026.
https://t.co/G1q7EVXREl [https://t.co/5BaRk85iCM]
⏰ Time is running out! Early Bird Registration for the BC3 closes July 30!
Don't miss your opportunity to save while securing your spot for 3 days of cutting-edge education.
https://t.co/zbLNJVmyK1
#BC32026#plasticsurgery#woundcare#CancerCare
Have you booked your room for BC3 yet? Discounted room rates expire next week and hotel has limited availability! Visit https://t.co/7VcPtZLVeN to stay onsite with us!
Congratulations to the 2022 Scott L. Spear, MD Tribute Award recipient! We cannot wait to honor your achievements during the 2022 conference. Register today at https://t.co/zbLNJVmyK1!
So much great information at #BC32020, it’s hard to choose! Would say 1) Get PM&R MDs like @EricWisotzkyMD involved early/often 2) surgical options for lymphedema continue to improve (though prevention is of course best) 3) interest in breast sensation is wonderfully widespread